Skip to content

Comparison of the effects of celecoxib and Novafen on pain and swelling after hard tissue surgery of impacted mandibular third molars in patients referred to a dental clinic

Comparison of the effects of celecoxib and Novafen on pain and swelling after hard tissue surgery of impacted mandibular third molars in patients referred to a dental clinic

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250109064327N1
Enrollment
62
Registered
2025-02-22
Start date
2025-01-29
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wisdom tooth surgery.

Interventions

Intervention 1: Intervention group: Celecoxib 100 every 12 hours for 3 days, reihane farmacy company. Intervention 2: Intervention group: Novafen (325 mg acetaminophen, 40 mg caffeine,200 mg ibuprufen

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Age range of 18-30 years sufficient literacy wisdom tooth with mesio angular impaction and the same degree of difficulty hard tissue surgery

Exclusion criteria

Exclusion criteria: Diabetic patients Existence of systemic drug interaction with the two drugs considered in this study Taking psychological drugs The presence of teeth with symptoms of pulpitis or necrosis in the patient's mouth smoking Drug abuse Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: 1, 3, 7 days after surgery. Method of measurement: Based on the visual analog scale of pain (VAS) (1-10).;Swelling rate. Timepoint: 1, 3, 7 days after surgery. Method of measurement: Clinical measurement based on the degree of swelling from the tragus of the ear to the corner of the mouth (1 to 10).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Mohebi

Islamic Azad University

amirhosseinmohebi79@gmail.com+98 31 3500 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026